Work

Efficacy and safety of adjunctive bitopertin (10 and 20mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the Phase III FlashLyte Study

Year: 2014

Type: article

Source: Schizophrenia Research

DOI: 10.1016/j.schres.2014.07.036

Authors: Thomas Blaettler, Dragana Bugarski-Kirola, W. Wolfgang Fleischhacker, Rodrigo Bressan, Celso Arango, Danielle Abi-Saab, Julie Napieralski, Mark Dixon, Stephen Marder

Institutions: F. Hoffmann-La Roche AG, Innsbruck Medical University, Universidade Federal de São Paulo, Hospital General Universitario Gregorio Marañón, University of California, Los Angeles

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4235423914

FWCI: 1.425

Cites:

Cited by: 11

Related to: 10